Seelos Therapeutics Announces the Selection of SLS-002 for Inclusion in the U.S. Department of Defenses Adaptive Platform Trial to Evaluate Potential Treatments for Post-Traumatic Stress Disorder
About 67% of Seelos Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Seelos Therapeutics suggests that many traders are alarmed regarding Seelos Therapeutics' prospects. Seelos Therapeutics' investing sentiment shows overall attitude of investors towards Seelos Therapeutics.
Seelos Therapeutics otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Seelos daily returns and investor perception about the current price of Seelos Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Seelos |
Seelos Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that SLS-002 has been selected for inclusion in an adaptive platform trial to evaluate treatments for post-traumatic stress disorder in active-duty service members and veterans. The trial is funded by the U.S. Department of Defenses Defense Health
Read at finance.yahoo.com
![]() |
Seelos Therapeutics Fundamental Analysis
We analyze Seelos Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Seelos Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Seelos Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Seelos Therapeutics is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Seelos Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Seelos Therapeutics otc stock to make a market-neutral strategy. Peer analysis of Seelos Therapeutics could also be used in its relative valuation, which is a method of valuing Seelos Therapeutics by comparing valuation metrics with similar companies.
Peers
Seelos Therapeutics Related Equities
TPST | Tempest Therapeutics | 1.16 | ||||
EWTX | Edgewise Therapeutics | 0.11 | ||||
CYBN | Cybin | 0.88 | ||||
ITOS | Iteos Therapeutics | 0.94 | ||||
ENTX | Entera Bio | 1.43 | ||||
OPT | Opthea | 2.39 | ||||
GHRS | GH Research | 2.40 | ||||
SLNO | Soleno Therapeutics | 2.43 | ||||
CAPR | Capricor Therapeutics | 3.67 | ||||
MOLN | Molecular Partners | 4.88 | ||||
MNMD | Mind Medicine | 5.90 | ||||
AKTX | Akari Therapeutics | 8.49 | ||||
ATAI | ATAI Life | 8.54 | ||||
PULM | Pulmatrix | 12.22 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in income. Note that the Seelos Therapeutics information on this page should be used as a complementary analysis to other Seelos Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Seelos OTC Stock
If you are still planning to invest in Seelos Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Seelos Therapeutics' history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |